Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center.
Peter J Schüffler, Luke Geneslaw, D Vijay K Yarlagadda, Matthew G Hanna, Jennifer Samboy, Evangelos Stamelos, Chad Vanderbilt, John Philip, Marc-Henri Jean, Lorraine Corsale, Allyne Manzo, Neeraj H G Paramasivam, John S Ziegler, Jianjiong Gao, Juan C Perin, Young Suk Kim, Umeshkumar K Bhanot, Michael H A Roehrl, Orly Ardon, Sarah Chiang, Dilip D Giri, Carlie S Sigel, Lee K Tan, Melissa Murray, Christina Virgo, Christine England, Yukako Yagi, S Joseph Sirintrapun, David Klimstra, Meera Hameed, Victor E Reuter and Thomas J Fuchs.
Journal of the American Medical Informatics Association, vol. 28, 9, p. 1874-1884, July 14, 2021
PDF URL BibTeX Endnote / RIS Abstract
Download BibTeX citation@article{schuffler_integrated_2021,
title = {Integrated digital pathology at scale: {A} solution for clinical diagnostics and cancer research at a large academic medical center},
volume = {28},
issn = {1527-974X},
shorttitle = {Integrated digital pathology at scale},
url = {https://doi.org/10.1093/jamia/ocab085},
doi = {10.1093/jamia/ocab085},
abstract = {Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes.We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a clinical or research context. It is the first homegrown viewer cleared by New York State provisional approval in 2020 for primary diagnosis and remote sign-out during the COVID-19 (coronavirus disease 2019) pandemic. We further introduce an interconnected Honest Broker for BioInformatics Technology (HoBBIT) to systematically compile and share large-scale DP research datasets including anonymized images, redacted pathology reports, and clinical data of patients with consent.The solution has been operationally used over 3 years by 926 pathologists and researchers evaluating 288 903 digital slides. A total of 51\% of these were reviewed within 1 month after scanning. Seamless integration of the viewer into 4 hospital systems clearly increases the adoption of DP. HoBBIT directly impacts the translation of knowledge in pathology into effective new health measures, including artificial intelligence–driven detection models for prostate cancer, basal cell carcinoma, and breast cancer metastases, developed and validated on thousands of cases.We highlight major challenges and lessons learned when going digital to provide orientation for other pathologists. Building interconnected solutions will not only increase adoption of DP, but also facilitate next-generation computational pathology at scale for enhanced cancer research.},
number = {9},
urldate = {2021-07-14},
journal = {Journal of the American Medical Informatics Association},
author = {Sch\"uffler, Peter J and Geneslaw, Luke and Yarlagadda, D Vijay K and Hanna, Matthew G and Samboy, Jennifer and Stamelos, Evangelos and Vanderbilt, Chad and Philip, John and Jean, Marc-Henri and Corsale, Lorraine and Manzo, Allyne and Paramasivam, Neeraj H G and Ziegler, John S and Gao, Jianjiong and Perin, Juan C and Kim, Young Suk and Bhanot, Umeshkumar K and Roehrl, Michael H A and Ardon, Orly and Chiang, Sarah and Giri, Dilip D and Sigel, Carlie S and Tan, Lee K and Murray, Melissa and Virgo, Christina and England, Christine and Yagi, Yukako and Sirintrapun, S Joseph and Klimstra, David and Hameed, Meera and Reuter, Victor E and Fuchs, Thomas J},
month = jul,
year = {2021},
pages = {1874--1884},
}
Download Endnote/RIS citationTY - JOUR
TI - Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center
AU - Schüffler, Peter J
AU - Geneslaw, Luke
AU - Yarlagadda, D Vijay K
AU - Hanna, Matthew G
AU - Samboy, Jennifer
AU - Stamelos, Evangelos
AU - Vanderbilt, Chad
AU - Philip, John
AU - Jean, Marc-Henri
AU - Corsale, Lorraine
AU - Manzo, Allyne
AU - Paramasivam, Neeraj H G
AU - Ziegler, John S
AU - Gao, Jianjiong
AU - Perin, Juan C
AU - Kim, Young Suk
AU - Bhanot, Umeshkumar K
AU - Roehrl, Michael H A
AU - Ardon, Orly
AU - Chiang, Sarah
AU - Giri, Dilip D
AU - Sigel, Carlie S
AU - Tan, Lee K
AU - Murray, Melissa
AU - Virgo, Christina
AU - England, Christine
AU - Yagi, Yukako
AU - Sirintrapun, S Joseph
AU - Klimstra, David
AU - Hameed, Meera
AU - Reuter, Victor E
AU - Fuchs, Thomas J
T2 - Journal of the American Medical Informatics Association
AB - Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes.We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a clinical or research context. It is the first homegrown viewer cleared by New York State provisional approval in 2020 for primary diagnosis and remote sign-out during the COVID-19 (coronavirus disease 2019) pandemic. We further introduce an interconnected Honest Broker for BioInformatics Technology (HoBBIT) to systematically compile and share large-scale DP research datasets including anonymized images, redacted pathology reports, and clinical data of patients with consent.The solution has been operationally used over 3 years by 926 pathologists and researchers evaluating 288 903 digital slides. A total of 51% of these were reviewed within 1 month after scanning. Seamless integration of the viewer into 4 hospital systems clearly increases the adoption of DP. HoBBIT directly impacts the translation of knowledge in pathology into effective new health measures, including artificial intelligence–driven detection models for prostate cancer, basal cell carcinoma, and breast cancer metastases, developed and validated on thousands of cases.We highlight major challenges and lessons learned when going digital to provide orientation for other pathologists. Building interconnected solutions will not only increase adoption of DP, but also facilitate next-generation computational pathology at scale for enhanced cancer research.
DA - 2021/07/14/
PY - 2021
DO - 10.1093/jamia/ocab085
DP - Silverchair
VL - 28
IS - 9
SP - 1874
EP - 1884
J2 - Journal of the American Medical Informatics Association
SN - 1527-974X
ST - Integrated digital pathology at scale
UR - https://doi.org/10.1093/jamia/ocab085
Y2 - 2021/07/14/21:13:00
ER -
Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, and educational use cases are missing. We blueprint a holistic DP solution at a large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, and tissue databases; and educational processes.We built a vendor-agnostic, integrated viewer for reviewing, annotating, sharing, and quality assurance of digital slides in a clinical or research context. It is the first homegrown viewer cleared by New York State provisional approval in 2020 for primary diagnosis and remote sign-out during the COVID-19 (coronavirus disease 2019) pandemic. We further introduce an interconnected Honest Broker for BioInformatics Technology (HoBBIT) to systematically compile and share large-scale DP research datasets including anonymized images, redacted pathology reports, and clinical data of patients with consent.The solution has been operationally used over 3 years by 926 pathologists and researchers evaluating 288 903 digital slides. A total of 51% of these were reviewed within 1 month after scanning. Seamless integration of the viewer into 4 hospital systems clearly increases the adoption of DP. HoBBIT directly impacts the translation of knowledge in pathology into effective new health measures, including artificial intelligence–driven detection models for prostate cancer, basal cell carcinoma, and breast cancer metastases, developed and validated on thousands of cases.We highlight major challenges and lessons learned when going digital to provide orientation for other pathologists. Building interconnected solutions will not only increase adoption of DP, but also facilitate next-generation computational pathology at scale for enhanced cancer research.